Earendil: A Blueprint for a Multipolar Life Sciences Era
By Joe Renny
June 5, 2026
The $787M financing points to a new global architecture in biotech
5 min read
False
Advertisement
Drug Discovery
HTC-19 Profile: What’s Cooking in the mRNA Lab?
June 3, 2026
Jonathan Maurer of the University of Geneva discusses his work with Sanofi and Waters – and why good analytical science has a lot in common with good cooking
3 min read
When Insight Meets Urgency in Cell and Gene Therapy
By Ruizhi Wang, Alan J. Dickson
May 27, 2026
Balancing deep biological insight with the realities of development is now central to progress in advanced medicine
6 min read
The Secrets of the Gut
April 20, 2026
Going beyond the gut: why microbiome testing is the next big thing in drug development
3 min read
Immune-Stealth DNA Enables Safer, Large-Scale Genome Writing
April 8, 2026
Circular single-stranded donors help recombinases bypass immune defenses, unlocking in vivo gene insertion
2 min read
Alzheimer’s Drug Lecanemab Works by “Switching On” the Brain’s Cleanup Cells
April 7, 2026
Study reveals Fc fragment of antibody is essential for activating microglia to clear amyloid plaques
2 min read
How AI is Reshaping Biologic Drug Discovery
April 6, 2026
Review charts rise of language models, AlphaFold, and generative AI in engineering next-generation therapeutics
2 min read
CAR-T Cells Target Alzheimer’s Plaques
April 6, 2026
Engineered immune cells clear amyloid and improve brain health in mice, offering a new direction for neurodegenerative therapy
1 min read
CRISPR “Gene Drive” Reverses Antibiotic Resistance in Bacteria
April 2, 2026
Population-wide editing system strips resistance genes – even inside hard-to-treat biofilms
2 min read
From One Stem Cell to Millions of Cancer Killers
April 1, 2026
A three-step engineering strategy generates vast numbers of potent NK immune cells – potentially slashing the cost and scaling of cancer immunotherapy
1 min read
